Thrombosis in conversation podcast

Episode 30: VTE and AF at ESC 2025

0:00
36:15
Spol 15 sekunder tilbage
Spol 15 sekunder frem

“I think this was such an important trial, certainly one that has changed my practice already.” Dr Barnes welcomes Dr Marco Proietti for a review and discussion of key studies presented at ESC 2025, including AMALFI, ALONE-AF, and HI-PRO. Which results were practice-changing, which were reassuring, and which are of uncertain value or highlight a need for new therapeutics?

Flere episoder fra "Thrombosis in conversation"